Respiratory Air Conditioning Devices Market - Size, Share, Outlook, and Opportun

Posted by priya saraf on July 17th, 2019

Respiratory air conditioning devices artificially modifies air for its humidity content and temperature before it is inhaled by the patient. Respiratory humidifier serves the essential functions of respiratory gas conditioning required for the sensitive lungs. This device plays an important role in patients whose natural respiratory humidification and warming fails. This may lead to worsening of pulmonary infections and damage of lung tissues.

Therefore, respiratory humidifier artificially warms and humidifies the air to be inhaled by the patients. Inhalation of dry and cold air by patients with compromised respiratory function may lead to the formation of thick mucus, which will affect the functioning of cilia and swelling of mucous membrane, blockage of air passages, and congestion of secretion in the respiratory apparatus. Respiratory heaters are useful to avoid these complications. These systems are utilized in both invasive and non-invasive ventilation and provides the physiological temperature of 37°C with the optimum of 100% relative humidity. Respiratory heaters are attached to the nebulizer system externally to provide controlled warming of the air for inhalation either through cannula or tracheotomy.

Request A Sample Copy: http://bit.ly/2NYZJQ3

Market Dynamics
Increasing prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis, and sometimes death of patients due to respiratory diseases are expected to drive growth of the respiratory air conditioning devices market. According to the World Health Organization (WHO) factsheet published in May 2018, chronic obstructive pulmonary disease and lower respiratory tract infection are amongst the top five chronic diseases that causes highest number of global death. There were around 3 million deaths due to chronic obstructive pulmonary disease in 2016. Lower respiratory tract infection also causes around 3 million deaths worldwide. Worsening of this disease leads to acute respiratory failure. Managing these diseases require the support of respiratory humidifiers and heaters, in order to avoid further complications and infections due to unconditioned air.

According to a study published in the New England Journal of Medicine in 2015, heated humidifier therapy has shown to improve patient outcomes and reduce mortality rates compared to non-invasive ventilation and standard oxygen therapy. Therefore, these factors are expected to boost growth of the global respiratory air conditioning devices market. New product launches would further propel the market demand for respiratory air conditioning devices. For instance, in October 2015, Teleflex launched Hudson RCI Comfort Flo plus High Flow Nasal Cannula, which expands the company’s portfolio of heated high flow nasal cannula therapy (HFNCT) solutions.

Competitive Landscape
Some of the key players operating in the global respiratory air conditioning devices market include Becton and Dickinson Corporation, Teleflex, Inc., WILAmed GmbH, ARMSTRONG MEDICAL, Respicare DME, Inc., GREAT GROUP MEDICAL CO., LTD., and Medline Industries, Inc.
Click To Read More On: Respiratory Air Conditioning Devices Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com